©2024 Stanford Medicine
Continuous Glucose Monitoring to Aid Weight Loss in Prediabetes
Not Recruiting
Trial ID: NCT03844646
Purpose
The primary objective of this study is to determine whether intermittent use of continuous
glucose monitor will facilitate weight loss in individuals who are overweight/obese with
prediabetes.
Official Title
Real-Time Continuous Glucose Monitoring to Aid Weight Loss in Prediabetes
Stanford Investigator(s)
Sun Kim, M.D. M.S.
Associate Professor of Medicine (Endocrinology)
Eligibility
Inclusion Criteria:
- Overweight/obese (BMI 25-40 kg/m2)
- Prediabetes (fasting glucose 100-125 mg/dL and/or HbA1c 5.7-6.4%)
Exclusion Criteria:
- On glucose-lowering medications (e.g., metformin)
- On weight-loss medications
Intervention(s):
device: CGM
other: Dietitian
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Associate Professor
650-723-8284